Skip to content
Search

Latest Stories

Businesses in Pakistan oppose strict lockdown

BUSINESS leaders in Karachi, Pakistan have opposed strict lockdown restrictions in the metropolis and urged the authorities to forcefully vaccinate the public to curb the fourth coronavirus wave, The News reported.

The reaction from businesses comes after the government announced a nine-day lockdown in the Sindh province with a special focus on Karachi in the wake of a sharp rise in the Covid-19 cases.


The Federation of Pakistan Chambers of Commerce and Industry (FPCCI) and Karachi Chambers of Commerce and Industry (KCCI) said it was impossible for them to pay salaries to workers due to the closure of industries and businesses.

"Pakistan's economic hub Karachi should not be completely locked down in the larger national interest," president FPCCI Mian Nasser Hyatt Maggo was quoted as saying in the news report.

"The only solution out of the current situation, without causing any harm to businesses and employment opportunities, is to allow business and economic activities under strict compliance of SOPs (standard operating procedures) and mandatory vaccination of the workforce."

"If industries and businesses remain under restrictions, we will not be able to pay salaries," he added.

He urged the government to review the strict restrictions that are hurting the businesses.

Chairman Businessmen Group Zubair Motiwala said the only workable solution to minimise the number of Covid cases is to forcefully get people vaccinated and ensure strict implementation of SOPs.

Motiwala stressed that the government should carry out an aggressive vaccination campaign and compel masses to get vaccinated at the earliest.

More For You

modi-trump-getty
Trump shakes hands with Modi during a joint press conference at Hyderabad House in New Delhi on February 25, 2020. (Photo: Getty Images)

Key issues in India, US trade talks

TRADE talks between India and the US have hit a roadblock over disagreements on duties for auto components, steel and farm goods, Indian government sources said to Reuters, dashing hopes of reaching an interim deal ahead of president Donald Trump's July 9 deadline to impose reciprocal tariffs.

Here are the key issues at play:

Keep ReadingShow less
Anil Agarwal

Vedanta Resources, which is based in the UK and owned by Indian billionaire Anil Agarwal, has been working on reducing its debt. (Photo credit: Getty Images)

Getty Images

Anil Agarwal’s Vedanta Resources signs £438 million refinancing deal

VEDANTA LTD said on Thursday that its parent company, Vedanta Resources, has signed a loan facility agreement worth up to £438 million with international banks to refinance existing debt.

The refinancing move, where old loans are replaced by new ones, often at better terms like lower interest rates, has led ratings agencies such as S&P Global Ratings and Moody's to upgrade their outlook on the company this year.

Keep ReadingShow less
Trump-Getty

Trump said that while deals are being made with some countries, others may face tariffs.

Getty Images

Trump says major trade deal with India may be finalised soon

US PRESIDENT Donald Trump on Friday said a "very big" trade deal could be finalised with India, suggesting significant movement in the ongoing negotiations between the two countries.

“We are having some great deals. We have one coming up, maybe with India. Very big one. Where we're going to open up India," Trump said at the “Big Beautiful Bill” event at the White House.

Keep ReadingShow less
Asda suffers nearly £600m loss as debt and IT costs surge

Asda co-ownerMohsin Issa. (Photo: Asda)

Asda suffers nearly £600m loss as debt and IT costs surge

ASDA, one of Britain’s largest supermarkets, has reported a pre-tax loss of £599 million for 2024, swinging sharply from a £180 million profit the previous year.

The loss comes despite total sales rising by over £1 billion to £26.8bn, as the retailer faces mounting debt costs, falling sales, and spiralling spending on a major IT overhaul, the Telegraph reported.

Keep ReadingShow less
Mounjaro

Mounjaro, or tirzepatide, is part of a new class of weight-loss medications, with trials showing patients losing an average of 20 per cent of their body weight after 72 weeks.

Reuters

Lilly to sell Mounjaro pens in India as Wegovy enters market

ELI LILLY said on Thursday that it has received approval from India's drug regulator to launch pre-filled injector pens of its weight-loss drug, Mounjaro.

The move gives the company more options to compete with Novo Nordisk, which recently launched its weight-loss drug Wegovy in the country.

Keep ReadingShow less